CSA Medical
PrivateLast Round
Seed Round
Jul 23, 2026
Total Funding Raised
$206.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CSA Medical is a medical device company that develops and commercializes the RejuvenAir® System, a liquid nitrogen spray cryotherapy technology for the treatment of chronic bronchitis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CSA Medical Comparables
Compare CSA Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galvanize Therapeutics | 88% | |
| Free Flow Medical, Inc. | 84% | |
| Nuvaira | 82% | |
CSA Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 23, 2026 | ||||
| Series D | Sep 9, 2024 | ||||
| Debt | Feb 8, 2019 | ||||
| Growth Equity | Jan 25, 2019 | ||||
| Growth Equity | Oct 8, 2018 | ||||
Debt | Oct 8, 2018 |
Key People
Founding team and executive leadership
CSA Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Growth Equity, Series D, Series C |
| SV Health Investors | Debt, Series C, Growth Equity, Series B, Series D |
| First Analysis | Series C, Series D, Series B |
| Ascension Ventures | Debt, Series D, Series C |
| TVM Capital | Series D |
| Guide Medical Ventures | Series C |
| Rose Park Advisors | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 233% MoM.
- Jul 23, 2026
Raised $3M in seed funding.
CSA Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |